DYADIC INTERNATIONAL INC Investing Cash Flow
DYADIC INTERNATIONAL INC (DYAI) reported Investing Cash Flow of $909.31 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-12
- DYADIC INTERNATIONAL INC net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$356.88K.
- DYADIC INTERNATIONAL INC net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $1.27M, a 162.64% increase year-over-year.
- DYADIC INTERNATIONAL INC net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $468.16K, a 62.94% decline year-over-year.
- DYADIC INTERNATIONAL INC net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $93.44K.
- DYADIC INTERNATIONAL INC net cash provided by (used in) investing activities for fiscal 2025 was $82.08K.
- DYADIC INTERNATIONAL INC net cash provided by (used in) investing activities for fiscal 2024 was -$1.88M, a 125.18% decline from fiscal 2023.
- DYADIC INTERNATIONAL INC net cash provided by (used in) investing activities for fiscal 2023 was $7.45M.
- DYADIC INTERNATIONAL INC net cash provided by (used in) investing activities for fiscal 2022 was -$2.37M, a 145.37% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$356.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $909.31K 10-Q · filed 2026-08-12 | $1.38M derived: sum of 3 quarters · filed 2026-08-12 | $1.47M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $1.27M 10-Q · filed 2026-05-13 | $1.73M derived: sum of 2 quarters · filed 2026-05-13 | $1.83M derived: sum of 3 quarters · filed 2026-05-13 | $866.18K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $468.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $561.60K derived: sum of 2 quarters · filed 2026-03-25 | -$400.02K derived: sum of 3 quarters · filed 2026-08-12 | $82.08K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $93.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$868.18K derived: sum of 2 quarters · filed 2026-08-12 | -$386.07K 10-Q · filed 2025-11-12 | $877.20K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | -$961.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$479.52K 10-Q · filed 2026-08-12 | $783.76K derived: sum of 3 quarters · filed 2026-08-12 | $771.78K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $482.10K 10-Q · filed 2026-05-13 | $1.75M derived: sum of 2 quarters · filed 2026-05-13 | $1.73M derived: sum of 3 quarters · filed 2026-05-13 | -$739.24K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.25M derived: sum of 2 quarters · filed 2026-03-25 | -$1.22M derived: sum of 3 quarters · filed 2026-03-25 | -$1.88M 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$11.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.48M derived: sum of 2 quarters · filed 2025-11-12 | -$3.14M 10-Q · filed 2025-11-12 | -$3.11M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$2.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.13M 10-Q · filed 2025-08-13 | -$3.09M derived: sum of 3 quarters · filed 2025-08-13 | $433.99K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$654.91K 10-Q · filed 2025-05-14 | -$620.75K derived: sum of 2 quarters · filed 2025-05-14 | $2.91M derived: sum of 3 quarters · filed 2025-05-14 | $4.03M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $34.15K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $3.56M derived: sum of 2 quarters · filed 2025-03-26 | $4.68M derived: sum of 3 quarters · filed 2025-03-26 | $7.45M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.65M derived: sum of 2 quarters · filed 2024-11-12 | $7.42M 10-Q · filed 2024-11-12 | $8.03M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $3.89M 10-Q · filed 2024-08-13 | $4.51M derived: sum of 3 quarters · filed 2024-08-13 | $3.20M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $2.77M 10-Q · filed 2024-05-14 | $3.39M derived: sum of 2 quarters · filed 2024-05-14 | $2.08M derived: sum of 3 quarters · filed 2024-05-14 | $918.81K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $617.92K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$692.01K derived: sum of 2 quarters · filed 2024-03-28 | -$1.85M derived: sum of 3 quarters · filed 2024-03-28 | -$2.37M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.47M derived: sum of 2 quarters · filed 2023-11-08 | -$2.99M 10-Q · filed 2023-11-08 | $1.51M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.68M 10-Q · filed 2023-08-09 | $2.82M derived: sum of 3 quarters · filed 2023-08-09 | $6.83M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | -$520.85K 10-Q · filed 2023-05-10 | -$520.85M 10-Q · filed 2022-05-12 | $3.98M derived: sum of 2 quarters · filed 2023-05-10 | $7.98M derived: sum of 3 quarters · filed 2023-05-10 | $5.79B derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $8.51M derived: sum of 2 quarters · filed 2023-03-29 | $5.79B derived: sum of 3 quarters · filed 2023-03-29 | $5.22M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $4.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $5.78B derived: sum of 2 quarters · filed 2022-11-10 | $721.59K 10-Q · filed 2022-11-10 | $759.80K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $5.78B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$3.28M 10-Q · filed 2022-08-10 | -$3.25M derived: sum of 3 quarters · filed 2022-08-10 | $8.21M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | -$5.78B 10-Q · filed 2022-05-12 | -$5.78M 10-Q · filed 2021-05-13 | -$5.78B derived: sum of 2 quarters · filed 2022-05-12 | -$5.77B derived: sum of 3 quarters · filed 2022-05-12 | -$5.76B derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $38.21K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $11.49M derived: sum of 2 quarters · filed 2022-03-29 | $20.42M derived: sum of 3 quarters · filed 2022-03-29 | $22.12M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $11.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $20.39M derived: sum of 2 quarters · filed 2021-11-10 | $22.08M 10-Q · filed 2021-11-10 | $23.42M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $8.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $10.63M 10-Q · filed 2021-08-12 | $11.97M derived: sum of 3 quarters · filed 2021-08-12 | $13.23M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $1.70M 10-Q · filed 2021-05-13 | $3.04M derived: sum of 2 quarters · filed 2021-05-13 | $4.30M derived: sum of 3 quarters · filed 2021-05-13 | $6.40M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $2.60M derived: sum of 2 quarters · filed 2021-03-30 | $4.70M derived: sum of 3 quarters · filed 2021-03-30 | $7.71M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $3.36M derived: sum of 2 quarters · filed 2020-11-12 | $6.37M 10-Q · filed 2020-11-12 | $8.28M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $5.10M 10-Q · filed 2020-08-13 | $7.01M derived: sum of 3 quarters · filed 2020-08-13 | $8.25M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $3.01M 10-Q · filed 2020-05-14 | $4.92M derived: sum of 2 quarters · filed 2020-05-14 | $6.15M derived: sum of 3 quarters · filed 2020-05-14 | $6.46M derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $3.14M derived: sum of 2 quarters · filed 2020-03-30 | $3.45M derived: sum of 3 quarters · filed 2020-03-30 | $3.33M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $1.54M derived: sum of 2 quarters · filed 2019-11-13 | $1.42M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $309.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $186.29K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | -$123.00K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | -$812.08K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |